Mark Namchuk Selected Research

Mark Namchuk Research Topics

2	Neoplasms (Cancer) 11/2017 - 03/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2012 - 10/2011
2	Reperfusion Injury 01/2006 - 03/2004
1	Weight Gain 10/2019
1	Insulin Resistance 10/2019
1	Schizophrenia (Dementia Praecox) 10/2019
1	Disease Progression 11/2017
1	Melanoma (Melanoma, Malignant) 11/2017
1	Chronic Disease (Chronic Diseases) 12/2015
1	Communicable Diseases (Infectious Diseases) 12/2015
1	Autoimmune Diseases (Autoimmune Disease) 09/2015
1	Hepatitis C 12/2009
1	Rheumatoid Arthritis 05/2007
1	Inflammation (Inflammations) 05/2007
1	Hypoxia (Hypoxemia) 01/2006
1	Atherosclerosis 03/2004
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2004
1	Hypertrophy 03/2004
1	Ventricular Remodeling 03/2004

2	Protein Kinases (Protein Kinase)IBA 01/2006 - 03/2004
1	3-carboxamido-4-hydroxynaltrexoneIBA 10/2019
1	Olanzapine (Zyprexa)FDA Link 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	Antipsychotic Agents (Antipsychotics)IBA 10/2019
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017
1	ulixertinibIBA 11/2017
1	Pharmaceutical PreparationsIBA 12/2015
1	Tyrosine (L-Tyrosine)FDA Link 09/2015
1	Janus Kinase 3IBA 09/2015
1	Phosphotransferases (Kinase)IBA 09/2015
1	2- ((2- (1H- pyrrolo(2,3- b)pyridin- 3- yl)pyrimidin- 4- yl)amino)- 2- methyl- N- (2,2,2- trifluoroethyl)butanamideIBA 09/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2012
1	N3- (4- (4- morpholinocyclohexyl)phenyl)- 1- (pyridin- 2- yl)- 1H- 1,2,4- triazole- 3,5- diamineIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 10/2011
1	fms-Like Tyrosine Kinase 3IBA 10/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2009
1	IsotopesIBA 12/2009
1	telaprevirIBA 12/2009
1	belnacasanIBA 05/2007
1	3-Phosphoinositide-Dependent Protein KinasesIBA 01/2006

3	Therapeutics 11/2017 - 03/2004
1	Injections 12/2015